901 - 950 of 8826 Results
Title
Year
- Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts2023RESTRICTEDTitle: Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 2Start Page: 733End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-023-12058-6Citation Count: 1
-
RESTRICTEDTitle: Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysisJournal Name: CytokinePublisher: Elsevier BVVol: 158Issue #:Start Page: 156006End Page: 156006Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cyto.2022.156006Best OA location URL: https://doi.org/10.1016/j.cyto.2022.156006Citation Count: 25
-
RESTRICTEDTitle: Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroupJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 29Issue #: 3Start Page: 611End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-023-02352-0Best OA location URL: https://www.nature.com/articles/s41380-023-02352-0.pdfCitation Count: 0
-
RESTRICTEDTitle: The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impactJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13836Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13836Citation Count: 0
- Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update2024RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 14Issue #: 5Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-240272Citation Count: 0
- Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology2024RESTRICTEDTitle: Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiologyJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 103Issue #:Start Page: 266End Page: 287Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2024.06.016Citation Count: 0
- BridGE: a pathway-based analysis tool for detecting genetic interactions from GWAS2024RESTRICTEDTitle: BridGE: a pathway-based analysis tool for detecting genetic interactions from GWASJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 5Start Page: 1400End Page: 1435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-024-00954-8Citation Count: 0
- Cognitive dysfunction in animal models of human lewy-body dementia2024RESTRICTEDTitle: Cognitive dysfunction in animal models of human lewy-body dementiaJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fnagi.2024.1369733Citation Count: 0
- Inflammation and heterogeneity in synucleinopathies2024RESTRICTEDTitle: Inflammation and heterogeneity in synucleinopathiesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fimmu.2024.1432342Citation Count: 0
- Synthesis at the Interface of Chemistry and Biology2024RESTRICTEDTitle: Synthesis at the Interface of Chemistry and BiologyJournal Name: Accounts of Chemical ResearchPublisher: American Chemical Society (ACS)Vol: 57Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.accounts.4c00320Citation Count: 0
- The immune system in Parkinson’s disease: what we know so far2024OPENTitle: The immune system in Parkinson’s disease: what we know so farJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae177Citation Count: 0
- Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing2024OPENTitle: Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA SequencingJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 61Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-024-04124-5Citation Count: 2
- A framework for translational therapy development in deep brain stimulation2024OPENTitle: A framework for translational therapy development in deep brain stimulationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00829-5Citation Count: 0
- The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses2024OPENTitle: The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapsesJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 87Issue #:Start Page: 102886End Page: 102886Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2024.102886Citation Count: 1
- The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis2024RESTRICTEDTitle: The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysisJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 459Issue #:Start Page: 122970End Page: 122970Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2024.122970Citation Count: 0
- Disease-Modifying Therapies in Parkinson’s Disease2025RESTRICTEDTitle: Disease-Modifying Therapies in Parkinson’s DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 43Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2024.12.009Citation Count: 0
- Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis2015RESTRICTEDTitle: Fanning the Flames in Anti-N-methyl-D-aspartate Receptor EncephalitisJournal Name: International Journal of Gynecological PathologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 401End Page: 402Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/pgp.0000000000000186Citation Count: 0
-
OPENTitle: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable FociJournal Name: SSRN Electronic JournalPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2139/ssrn.4260648Best OA location URL: https://doi.org/10.1101/2022.09.18.508419Citation Count: 2
-
OPENTitle: Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study dataJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100342End Page: 100342Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100342Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100342Citation Count: 0
- Stride width and postural stability in frontal gait disorders and Parkinson’s disease2024RESTRICTEDTitle: Stride width and postural stability in frontal gait disorders and Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 7Start Page: 3721End Page: 3730Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-024-12401-5Citation Count: 4
- Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson’s disease and ageing research2025OPENTitle: Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson’s disease and ageing researchJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01088-8Citation Count: 0
-
RESTRICTEDTitle: Adaptive immunity in the pathogenesis and treatments of Parkinson’s diseaseJournal Name: NeuroImmune Pharmacology and TherapeuticsPublisher: Walter de Gruyter GmbHVol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1515/nipt-2025-0008Best OA location URL: https://www.degruyterbrill.com/document/doi/10.1515/nipt-2025-0008/pdfCitation Count: 0
-
OPENTitle: Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical TranslationJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 15Start Page: 1161End Page: 1161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14151161Best OA location URL: https://www.mdpi.com/2073-4409/14/15/1161/pdf?version=1753706875Citation Count: 0
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019RESTRICTEDTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk2018RESTRICTEDTitle: Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable riskJournal Name:Publisher:Vol:Issue #:Start Page: 388165End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 4
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Finding useful biomarkers for Parkinson's disease2018RESTRICTEDTitle: Finding useful biomarkers for Parkinson's diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 2
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Validation of Fox Insight Cohort via Virtual Research Visits (4749)2020RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
- Novel therapeutic approaches to target neurodegeneration2022RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/au.167164898.84768756Citation Count: 0
- Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental Sciences2023RESTRICTEDTitle: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental SciencesJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758Citation Count: 1
- Journal Production Guidance for Software and Data Citations2022RESTRICTEDTitle: Journal Production Guidance for Software and Data CitationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.167252601.17695321Citation Count: 0
- Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small Dataset2020RESTRICTEDTitle: Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small DatasetJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21203/rs.3.rs-19405Citation Count: 3
- Neurochemical biomarkers in the differential diagnosis of movement disorders2009RESTRICTEDTitle: Neurochemical biomarkers in the differential diagnosis of movement disordersJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 10Start Page: 1411End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22510Citation Count: 43
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
RESTRICTEDTitle: Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammationJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 6Start Page: 681End Page: 696Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00281-020-00819-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-020-00819-8.pdfCitation Count: 10
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
-
RESTRICTEDTitle: Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophreniaJournal Name: Brain InformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40708-020-00112-2Best OA location URL: https://braininformatics.springeropen.com/track/pdf/10.1186/s40708-020-00112-2Citation Count: 182
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease2021RESTRICTEDTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8;Citation Count: 68
- Mitochondrial isolation: when size matters2020RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name:Publisher:Vol:Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.1;Citation Count: 3
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2019RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name:Publisher:Vol:Issue #:Start Page: 216847901881751End Page: 216847901881751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/2168479018817517;Citation Count: 21
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
-
RESTRICTEDTitle: Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery SystemsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s2Start Page: S229End Page: S236Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212662Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212662?id=journal-of-parkinsons-disease%2Fjpd212662Citation Count: 6